The effects of intravenous lidocaine administration on the minimum alveolar concentration of isoflurane in cats

Anesthesia and Analgesia

Volumn 100, Issue 1, 2005, Pages 97-101

  Pypendop, Bruno H ^a   Ilkiw, Jan E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLURANE; LIDOCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CAT; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANESTHETICS, INHALATION; ANESTHETICS, LOCAL; ANIMALS; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ISOFLURANE; LIDOCAINE; NONLINEAR DYNAMICS; PULMONARY ALVEOLI;

EID: 10944245380     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000139350.88158.38     Document Type: Article

References (20)

1. Bailey PL, Egan TD, Stanley TH. Intravenous opioid anesthetics. In: Miller RD, ed. Anesthesia, 5th ed. Philadelphia: Churchill Livingstone, 2000:273-376.
2. DiFazio CA, Neiderlehner JR, Burney RC. The anesthetic potency of lidocaine in the rat. Anesth Analg 1976;55:818-21.
3. Doherty TJ, Frazier DL. Effect of intravenous lidocaine on halothane minimum alveolar concentration in ponies. Equine Vet J 1998;30:300-3.
4. Himes RS Jr, DiFazio CA, Burney RG. Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology 1977;47:437-40.
5. Himes RS Jr, Munson ES, Embro WJ. Enflurane requirement and ventilatory response to carbon dioxide during lidocaine infusion in dogs. Anesthesiology 1979;51:131-4.
6. Dzikiti TB, Hellebrekers LJ, van Dijk P. Effects of intravenous lidocaine on isoflurane concentration, physiological parameters, metabolic parameters and stress-related hormones in horses undergoing surgery. J Vet Med A Physiol Pathol Clin Med 2003;50:190-5.
7. Steinhaus JE, Howland DE. Intravenous administered lidocaine as a supplement to nitrous oxide-thiobarbiturate anesthesia. Anesth Analg 1958;37:40-6.
8. de Clive-Lowe SG, Desmond J, North J. Intravenous lignocaine anaesthesia. Anaesthesia 1958;13:138-46.
9. Phillips OC, Lyons WB, Harris LC, et al. Intravenous lidocaine as an adjunct to general anesthesia: a clinical evaluation. Anesth Analg 1960;39:317-22.
10. Gibaldi M, Perrier D. Multicompartment models. In: Gibaldi M, ed. Pharmacokinetics, 2nd ed. New York: Marcel Decker, 1982:45-109.
11. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-75.
12. Keenaghan JB, Boyes RN. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. J Pharmacol Exp Ther 1972;180:454-63.
13. Narang PK, Crouthamel WG, Carliner NH, Fisher ML. Lidocaine and its active metabolites. Clin Pharmacol Ther 1978;24:654-62.
14. Hanna IH, Roberts ES, Hollenberg PF. Molecular basis for the differences in lidocaine binding and regioselectivity of oxidation by cytochromes P450 2B1 and 2B2. Biochemistry 1998;37:311-8.
15. Burney RG, DiFazio CA, Peach MJ, et al. Anti-arrhythmic effects of lidocaine metabolites. Am Heart J 1974;88:765-9.
16. Rehberg B, Xiao YH, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology 1996;84:1223-33.
17. Bach FW, Jensen TS, Kastrup J, et al. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990;40:29-34.
18. Butterworth J, Cole L, Marlow G. Inhibition of brain cell excitability by lidocaine, QX314, and tetrodotoxin: a mechanism for analgesia from infused local anesthetics? Acta Anaesthesiol Scand 1993;37:516-23.
19. de Jong RH, Ronfeld RA, DeRosa RA. Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics. Anesth Analg 1982;61:3-9.
20. Murao K, Shingu K, Tsushima K, et al. The anticonvulsant effects of volatile anesthetics on lidocaine-induced seizures in cats. Anesth Analg 2000;90:148-55.